feature photo

New funding strengthens UVic’s national leadership in protein research

January 23, 2018 - Media release

Improved diagnosis and treatment of a range of diseases such as cancer and Alzheimer's will be the outcome of more than $18 million in funding awarded today to two national research platforms in which the University of Victoria plays a key role. UVic's Christoph Borchers, an internationally recognized protein chemist and director of the UVic-Genome BC Proteomics Centre, is leading a new pan-Canadian proteomics research platform.

Read more: New funding strengthens UVic’s national leadership in protein research
feature photo

New funding boosts two UVic proteomics research projects

December 13, 2016 - Media release

A project co-led by UVic biochemist Christoph Borchers will use more than $3.8 million in new funding from Genome Canada to make mouse models more powerful and meaningful to the study of health and disease. Also funded is UVic chemist Fraser Hof, who receives $238,800 to investigate “methylation”—the smallest form of biochemical control switch.

Read more: New funding boosts two UVic proteomics research projects
feature photo

Just one drop: UVic-based technology set to revolutionize standard blood tests

January 20, 2016 - Ring

A small six-person team of scientists and lab technicians are leading a global revolution in medical diagnostics—from right here, in Victoria. Healthy or not, all of us at some time have been subjected to one of the most common forms of medial diagnostics—the dreaded blood test. But what if there was a way to avoid this uncomfortable process?

Read more: Just one drop: UVic-based technology set to revolutionize standard blood tests

Advances in mouse proteomics

October 22, 2014 - Ring

Proteomics—the study of proteins found in human cells and how they regulate their actions—is one of the most promising areas for developing new therapies for human diseases. Mouse models are the mainstay of most biomedical research, but researchers are limited by the small volumes of blood that can be sampled from live animals. Now, using $1.2 million in new funding from Genome BC and Genome Canada, the UVic-Genome BC Proteomics Centre and spinoff company MRM Proteomics Inc. will continue their work to develop new tools to help medical researchers measure the concentration of individual proteins in mouse plasma.

Read more: Advances in mouse proteomics

Proteomics pioneer to chair Genome BC-McGill collaboration

October 17, 2014 - Ring

Dr. Christoph Borchers, director of the UVic-Genome BC Proteomics Centre, has been jointly appointed as the Proteomics Chair for the Jewish General Hospital at McGill University in Montreal. Borchers is an expert in the use of mass spectrometry to study the structure and function of proteins. At the UVic centre, Borchers directs a research program that applies proteomics technologies to areas such as medical diagnostics, drug development, forestry and alternative fuels.

Read more: Proteomics pioneer to chair Genome BC-McGill collaboration
feature photo

Funding to help UVic-Genome BC Proteomics Centre

November 4, 2011 - Ring

Dr. Christoph Borchers (left), director of the UVic-Genome BC Proteomics Centre, shows off one of two new mass spectrometers to John Duncan, MP for Vancouver Island North and Minister of Aboriginal Affairs and Northern Development. The minister visited the proteomics centre on Oct. 12 to announce $663,000 in funding from the federal Western Diversification Program to purchase the two instruments. Mass spectrometers are powerful instruments that can identify a protein or part of a protein by its molecular weight. These two will be used to detect biomarkers—molecules that indicate the presence of disease such as cancer. The centre has the highest concentration of mass spectrometers at any Canadian university and one of the highest in North America.  

Read more: Funding to help UVic-Genome BC Proteomics Centre

  • < Newer
  • 1
  • Older >